• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

喂养多样化的蛋白质来源会通过增加肠道微生物支链脂肪酸和 mTORC1 信号通路使肥胖小鼠的肝胰岛素抵抗恶化。

Feeding diversified protein sources exacerbates hepatic insulin resistance via increased gut microbial branched-chain fatty acids and mTORC1 signaling in obese mice.

机构信息

Quebec Heart and Lung Institute (IUCPQ), Université Laval, Québec, Canada.

Institute of Nutrition and Functional Foods (INAF), Université Laval, Québec, Canada.

出版信息

Nat Commun. 2021 Jun 7;12(1):3377. doi: 10.1038/s41467-021-23782-w.

DOI:10.1038/s41467-021-23782-w
PMID:34099716
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8184893/
Abstract

Animal models of human diseases are classically fed purified diets that contain casein as the unique protein source. We show that provision of a mixed protein source mirroring that found in the western diet exacerbates diet-induced obesity and insulin resistance by potentiating hepatic mTORC1/S6K1 signaling as compared to casein alone. These effects involve alterations in gut microbiota as shown by fecal microbiota transplantation studies. The detrimental impact of the mixed protein source is also linked with early changes in microbial production of branched-chain fatty acids (BCFA) and elevated plasma and hepatic acylcarnitines, indicative of aberrant mitochondrial fatty acid oxidation. We further show that the BCFA, isobutyric and isovaleric acid, increase glucose production and activate mTORC1/S6K1 in hepatocytes. Our findings demonstrate that alteration of dietary protein source exerts a rapid and robust impact on gut microbiota and BCFA with significant consequences for the development of obesity and insulin resistance.

摘要

动物疾病模型通常采用含有酪蛋白作为唯一蛋白质来源的纯化饮食。我们发现,与单独使用酪蛋白相比,提供模拟西方饮食中发现的混合蛋白质来源会加剧饮食诱导的肥胖和胰岛素抵抗,从而增强肝脏 mTORC1/S6K1 信号传导。这些影响涉及肠道微生物群的改变,正如粪便微生物群移植研究所示。混合蛋白质来源的有害影响还与微生物产生支链脂肪酸 (BCFA) 的早期变化以及血浆和肝酰基辅酶 A 的升高有关,这表明线粒体脂肪酸氧化异常。我们进一步表明,支链脂肪酸,异丁酸和异戊酸增加葡萄糖生成并在肝细胞中激活 mTORC1/S6K1。我们的研究结果表明,饮食蛋白质来源的改变会对肠道微生物群和 BCFA 产生快速而强烈的影响,这对肥胖和胰岛素抵抗的发展有重大影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa03/8184893/c205e5ad388a/41467_2021_23782_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa03/8184893/d933dcc17073/41467_2021_23782_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa03/8184893/65287607f621/41467_2021_23782_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa03/8184893/807e8fb79013/41467_2021_23782_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa03/8184893/b46caed06868/41467_2021_23782_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa03/8184893/e146ce54f946/41467_2021_23782_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa03/8184893/bea318e09feb/41467_2021_23782_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa03/8184893/c205e5ad388a/41467_2021_23782_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa03/8184893/d933dcc17073/41467_2021_23782_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa03/8184893/65287607f621/41467_2021_23782_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa03/8184893/807e8fb79013/41467_2021_23782_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa03/8184893/b46caed06868/41467_2021_23782_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa03/8184893/e146ce54f946/41467_2021_23782_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa03/8184893/bea318e09feb/41467_2021_23782_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa03/8184893/c205e5ad388a/41467_2021_23782_Fig7_HTML.jpg

相似文献

1
Feeding diversified protein sources exacerbates hepatic insulin resistance via increased gut microbial branched-chain fatty acids and mTORC1 signaling in obese mice.喂养多样化的蛋白质来源会通过增加肠道微生物支链脂肪酸和 mTORC1 信号通路使肥胖小鼠的肝胰岛素抵抗恶化。
Nat Commun. 2021 Jun 7;12(1):3377. doi: 10.1038/s41467-021-23782-w.
2
Low-Molecular-Weight Peptides from Salmon Protein Prevent Obesity-Linked Glucose Intolerance, Inflammation, and Dyslipidemia in LDLR-/-/ApoB100/100 Mice.源自三文鱼蛋白的低分子量肽可预防LDLR-/-/ApoB100/100小鼠中与肥胖相关的葡萄糖不耐受、炎症和血脂异常。
J Nutr. 2015 Jul;145(7):1415-22. doi: 10.3945/jn.114.208215. Epub 2015 May 20.
3
Pharmacological inhibition of S6K1 increases glucose metabolism and Akt signalling in vitro and in diet-induced obese mice.S6K1的药理学抑制在体外和饮食诱导的肥胖小鼠中增加葡萄糖代谢和Akt信号传导。
Diabetologia. 2016 Mar;59(3):592-603. doi: 10.1007/s00125-015-3839-6. Epub 2016 Jan 5.
4
The Transplantation of ω3 PUFA-Altered Gut Microbiota of fat-1 Mice to Wild-Type Littermates Prevents Obesity and Associated Metabolic Disorders.ω3PUFA 改变的 fat-1 小鼠肠道微生物群的移植可预防肥胖及其相关代谢紊乱。
Diabetes. 2018 Aug;67(8):1512-1523. doi: 10.2337/db17-1488. Epub 2018 May 23.
5
Impact of different hypercaloric diets on obesity features in rats: a metagenomics and metabolomics integrative approach.不同高热能饮食对大鼠肥胖特征的影响:宏基因组学和代谢组学综合分析方法。
J Nutr Biochem. 2019 Sep;71:122-131. doi: 10.1016/j.jnutbio.2019.06.005. Epub 2019 Jun 21.
6
Gut microbiota mediates the protective effects of dietary β-hydroxy-β-methylbutyrate (HMB) against obesity induced by high-fat diets.肠道微生物群介导膳食 β-羟基-β-甲基丁酸(HMB)对高脂肪饮食诱导肥胖的保护作用。
FASEB J. 2019 Sep;33(9):10019-10033. doi: 10.1096/fj.201900665RR. Epub 2019 Jun 5.
7
The gut microbiota drives the impact of bile acids and fat source in diet on mouse metabolism.肠道微生物群驱动胆汁酸和脂肪源在饮食中对小鼠代谢的影响。
Microbiome. 2018 Aug 2;6(1):134. doi: 10.1186/s40168-018-0510-8.
8
Effect of a long-term high-protein diet on survival, obesity development, and gut microbiota in mice.长期高蛋白饮食对小鼠生存、肥胖发展及肠道微生物群的影响。
Am J Physiol Endocrinol Metab. 2016 Jun 1;310(11):E886-99. doi: 10.1152/ajpendo.00363.2015. Epub 2016 Mar 29.
9
Dietary fat and gut microbiota interactions determine diet-induced obesity in mice.膳食脂肪和肠道微生物群的相互作用决定了小鼠的饮食诱导肥胖。
Mol Metab. 2016 Oct 13;5(12):1162-1174. doi: 10.1016/j.molmet.2016.10.001. eCollection 2016 Dec.
10
The microbiota-dependent tryptophan metabolite alleviates high-fat diet-induced insulin resistance through the hepatic AhR/TSC2/mTORC1 axis.菌群依赖的色氨酸代谢产物通过肝脏 AhR/TSC2/mTORC1 轴缓解高脂饮食诱导的胰岛素抵抗。
Proc Natl Acad Sci U S A. 2024 Aug 27;121(35):e2400385121. doi: 10.1073/pnas.2400385121. Epub 2024 Aug 21.

引用本文的文献

1
Effects of Three Microbiome-Based Therapies on Loperamide-Induced Constipation in Mice by Restoring Intestinal Motility and Modulating the Intestinal Microbiota.三种基于微生物群的疗法通过恢复肠道蠕动和调节肠道微生物群对小鼠洛哌丁胺诱导的便秘的影响。
Probiotics Antimicrob Proteins. 2025 Aug 27. doi: 10.1007/s12602-025-10732-x.
2
Dietary protein sources in concentrate supplementation influence growth performance by manipulating gut microbiota and serum metabolites in suckling Donkey foals.在哺乳期小驴驹中,精料补充料中的膳食蛋白质来源通过调控肠道微生物群和血清代谢物来影响生长性能。
Anim Microbiome. 2025 Aug 26;7(1):91. doi: 10.1186/s42523-025-00457-1.
3

本文引用的文献

1
Muscle-Liver Trafficking of BCAA-Derived Nitrogen Underlies Obesity-Related Glycine Depletion.支链氨基酸衍生的氮在肌肉-肝脏之间的转运是肥胖相关甘氨酸耗竭的基础。
Cell Rep. 2020 Nov 10;33(6):108375. doi: 10.1016/j.celrep.2020.108375.
2
Dietary Protein Consumption and the Risk of Type 2 Diabetes: ADose-Response Meta-Analysis of Prospective Studies.饮食蛋白质摄入与 2 型糖尿病风险:前瞻性研究的剂量-反应荟萃分析。
Nutrients. 2019 Nov 15;11(11):2783. doi: 10.3390/nu11112783.
3
Dietary quality and the colonic mucosa-associated gut microbiome in humans.
Gut-liver axis in diabetes: Mechanisms and therapeutic opportunities.
糖尿病中的肠-肝轴:机制与治疗机遇
World J Gastroenterol. 2025 Aug 7;31(29):109090. doi: 10.3748/wjg.v31.i29.109090.
4
Unraveling the complexities of diet induced obesity and glucolipid dysfunction in metabolic syndrome.解析代谢综合征中饮食诱导的肥胖和糖脂功能障碍的复杂性。
Diabetol Metab Syndr. 2025 Jul 22;17(1):292. doi: 10.1186/s13098-025-01837-y.
5
Glucose release kinetics of different feed ingredients and their impact on short-term growth of pigs by influencing carbon-nitrogen supply synchronization.不同饲料原料的葡萄糖释放动力学及其通过影响碳氮供应同步性对猪短期生长的影响。
J Anim Sci Biotechnol. 2025 May 22;16(1):72. doi: 10.1186/s40104-025-01198-6.
6
Isobutyrate Confers Resistance to Inflammatory Bowel Disease through Host-Microbiota Interactions in Pigs.异丁酸盐通过猪体内宿主-微生物群相互作用赋予对炎症性肠病的抗性。
Research (Wash D C). 2025 May 8;8:0673. doi: 10.34133/research.0673. eCollection 2025.
7
Circulating short-chain and branched short-chain fatty acids and the risk of incident type 2 diabetes: findings from the 4C study.循环短链和支链短链脂肪酸与2型糖尿病发病风险:4C研究结果
Life Metab. 2025 Jan 22;4(2):loaf001. doi: 10.1093/lifemeta/loaf001. eCollection 2025 Apr.
8
Serum metabolomic profiling uncovered metabolic shifts in individuals upon moderate-altitude exposure and identified the potentiality of beta-alanine to ameliorate hyperuricemia.血清代谢组学分析揭示了个体在中度海拔暴露后的代谢变化,并确定了β-丙氨酸改善高尿酸血症的潜力。
Redox Biol. 2025 Apr;81:103546. doi: 10.1016/j.redox.2025.103546. Epub 2025 Feb 28.
9
Sucrose-preferring gut microbes prevent host obesity by producing exopolysaccharides.偏好蔗糖的肠道微生物通过产生胞外多糖来预防宿主肥胖。
Nat Commun. 2025 Jan 29;16(1):1145. doi: 10.1038/s41467-025-56470-0.
10
Tailored impact of dietary fibers on gut microbiota: a multi-omics comparison on the lean and obese microbial communities.膳食纤维对肠道微生物群的个性化影响:瘦型和肥胖型微生物群落的多组学比较。
Microbiome. 2024 Nov 30;12(1):250. doi: 10.1186/s40168-024-01975-x.
膳食质量与人类结肠黏膜相关的肠道微生物组。
Am J Clin Nutr. 2019 Sep 1;110(3):701-712. doi: 10.1093/ajcn/nqz139.
4
Supplementation with Akkermansia muciniphila in overweight and obese human volunteers: a proof-of-concept exploratory study.在超重和肥胖的人类志愿者中补充 Akkermansia muciniphila:概念验证性探索性研究。
Nat Med. 2019 Jul;25(7):1096-1103. doi: 10.1038/s41591-019-0495-2. Epub 2019 Jul 1.
5
Macronutrient metabolism by the human gut microbiome: major fermentation by-products and their impact on host health.人体肠道微生物组的宏量营养素代谢:主要发酵副产物及其对宿主健康的影响。
Microbiome. 2019 Jun 13;7(1):91. doi: 10.1186/s40168-019-0704-8.
6
Biosynthesis, regulation, and engineering of microbially produced branched biofuels.微生物生产的支链生物燃料的生物合成、调控与工程
Biotechnol Biofuels. 2019 Apr 13;12:84. doi: 10.1186/s13068-019-1424-9. eCollection 2019.
7
Faecal bacterial and short-chain fatty acids signature in hypercholesterolemia.高脂血症中的粪便细菌和短链脂肪酸特征。
Sci Rep. 2019 Feb 11;9(1):1772. doi: 10.1038/s41598-019-38874-3.
8
Branched-chain amino acids in disease.疾病中的支链氨基酸
Science. 2019 Feb 8;363(6427):582-583. doi: 10.1126/science.aav0558.
9
Gut microbial metabolites in obesity, NAFLD and T2DM.肥胖、非酒精性脂肪性肝病和 T2DM 中的肠道微生物代谢产物。
Nat Rev Endocrinol. 2019 May;15(5):261-273. doi: 10.1038/s41574-019-0156-z.
10
Microbial Fermentation of Dietary Protein: An Important Factor in Diet⁻Microbe⁻Host Interaction.膳食蛋白质的微生物发酵:饮食-微生物-宿主相互作用中的一个重要因素。
Microorganisms. 2019 Jan 13;7(1):19. doi: 10.3390/microorganisms7010019.